BIVI

BIOVIE INC.

NasdaqHealthcarePharmaceutical Preparations

Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingAug 29, 2026Most recent Form 4
Total buying$4.91M4 buys
Total selling$00 sells
Net open-market+$4.91M4 insiders
Open-market mix
Buy vs sell distribution by transaction count
4 transactions
4 buys100%·0%0 sells

Insider activity report

Monthly open-market purchase and sale counts
Buys Sells
530-3-5transactionsAug 2026 buys: 4 transactions · $4.91M4AugSep

Transaction codes

By Form 4 transaction code in selected period
4transactions
  • P · Open-market buys · dominant4 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
5transactions
  • Chief executive officer · dominant1 · 20%
  • Chief financial officer1 · 20%
  • CMO1 · 20%
  • Director1 · 20%
  • PRES1 · 20%

Distinct insiders active

Reporting-owner CIKs by month · peak Aug 2026 (4)
Aug 2026Sep 2026
4distinct insiders in 2 months

Reported Holdings After

Separated by insider, security, and ownership type
Do Cuong VCommon Stock · Direct
16.1k16.1kAug 27, 2026 · 16,117 shares owned afterAug 27, 2026Aug 27, 2026
16,117Aug 27, 2026
Kim Joanne WendyCommon Stock · Direct
3.4k3.4kAug 28, 2026 · 3,441 shares owned afterAug 28, 2026Aug 28, 2026
3,441Aug 28, 2026
Chappell Amy SuzonCommon Stock · Direct
727727Aug 28, 2026 · 727 shares owned afterAug 28, 2026Aug 28, 2026
727Aug 28, 2026
Palumbo Joseph MCommon Stock · Direct
6.0k6.0kAug 28, 2026 · 6,036 shares owned afterAug 28, 2026Aug 28, 2026
6,036Aug 28, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
0 active days
Aug 03Sep 03
LessMore

Filing detail checks

Secondary metrics for the selected period
Largest buy$3.16M
Largest sale-
10b5-1 detected0
Amended rows0

Filing-only signals

Deterministic matches in the selected period

BIVI transaction history

Filters apply within this company and selected period by default
Reset
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date

No transactions match your filters

Once the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range.

BIOVIE INC. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at BIOVIE INC.?

Palumbo Joseph M, Chappell Amy Suzon, KIM JOANNE WENDY, DO CUONG V.

When was the latest reported open-market purchase?

Palumbo Joseph M reported a buy on Aug 28, 2026 valued at $1.04M. Read the SEC filing.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

Net open-market buying in the selected period was $49,118.00. This describes filed transactions, not a bullish rating.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.